Celgene

NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019

CELG Articles

Celgene, Campbell's Soup, Banco Santander, and Teekay Tankers all posted new 52-week lows on Monday.
Campbell Soup, Cemex, Celgene, and Coty all posted new 52-week lows Friday.
Celgene, NetEase, PPL Corp., and Vodafone all posted new 52-week lows Thursday.
The April 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Tower Semiconductor, Cemex, Celgene, and Sibanye Gold all posted new 52-week lows Monday.
The April 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The March 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Celgene is shuffling the deck in terms of its executive leadership, and one of its top executives is stepping down.
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
This collaboration with Celgene looks like a chance for Prothena to really shine, especially considering that it has had a rough run of 2018 so far.
The top analyst upgrades, downgrades and other research calls from Wednesday include Applied Materials, Celgene, Children's Place, Kinder Morgan, Match, Myriad Genetics, Nordstrom and Oracle.
The February 28 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
Celgene, Weatherford International, Akorn, and Cemex all posted new 52-week lows on Wednesday.
Celgene watched its shares drop on Wednesday after the company announced that it received a Refusal to File letter from the FDA.